Second Trimester Abortion
13
1
1
6
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 54/100
23.1%
3 terminated out of 13 trials
66.7%
-19.8% vs benchmark
38%
5 trials in Phase 3/4
50%
3 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (13)
Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement
TENS Unit To Decrease Pain After Laminaria Insertion
MisOpRostol Effect on Second Trimester Abortion Blood Loss
Pharmacological Inhibition of Lactation After 16 to 20 Week Abortion
The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination
Cervical Preparation With Mifepristone Prior to Osmotic Dilators
Midlevel Versus Physician-provided Medical Abortion in the Second Trimester
Pilot Study of an Ambulatory Medical Abortion Service at 13-18 Weeks of Gestation in Colombia
Laminaria Compared to Dilapan-S for Cervical Preparation Before Dilation and Evacuation at 18-24 Weeks of Gestation
Second Trimester Pregnancy Termination in Women With Previous Caesarean Sections
Uterocervical Angle in the Pregnancy Termination of Multiparous Women
Misoprosotol and Isosorbide Mononitrate for Induction of Second Trimester Abortion
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second Trimester Abortion